ClinicalTrials.Veeva

Menu

Web-Delivered Acceptance & Commitment Therapy for Smokers With Bipolar Disorder (WebQuit Plus)

Fred Hutchinson Cancer Center (FHCC) logo

Fred Hutchinson Cancer Center (FHCC)

Status

Completed

Conditions

Bipolar Disorder
Smoking

Treatments

Behavioral: Control plus Nicotine Replacement Therapy
Behavioral: Experimental plus Nicotine Replacement Therapy

Study type

Interventional

Funder types

Other

Identifiers

NCT02750904
IR File# 8363

Details and patient eligibility

About

This purpose of the study is to develop and test a new website to help people who have bipolar disorder quit smoking.

Full description

The study consist of two separate phases. Phase I consists of website usability testing. Investigators will collect feedback and incorporate the feedback into our website that is tailored for people with bipolar disorder. In Phase II investigators will be comparing quit rates of two groups both utilizing Nicotine Replacement Therapy and a website.

Enrollment

51 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Age 18 or older
  2. Daily smoker for the past year, averaging at least 5 cigarettes per day for the past 30 days, with expired-air carbon monoxide (CO) level ≥ 4 ppm
  3. Motivated to quit smoking (i.e., endorse plans to quit in the next 30 days at the time of phone pre-screening)
  4. Meets lifetime criteria for bipolar I or II disorder, based on DSM-V criteria
  5. Willing to be randomly assigned to either treatment group
  6. Has at least weekly access to a high-speed Internet connection via a tablet, laptop or desktop computer
  7. Willing and able to read in English
  8. Is under care of a clinician for the treatment of bipolar disorder
  9. Willing to authorize communication with the clinician regarding study participation and clinical deterioration
  10. Willing to use the nicotine patch to help quit smoking

Exclusion criteria

  1. Participating in other smoking cessation interventions
  2. Currently using any pharmacotherapies for smoking cessation
  3. Previous use of the Smokefree.gov website
  4. Meets DSM-V criteria for current mania
  5. Meets DSM-V criteria for a current major depressive episode and symptoms are currently severe (Patient Health Questionnaire-9 score > 14)
  6. Current psychotic symptoms
  7. Psychiatric hospitalization within one month prior to enrollment
  8. Current suicidal or homicidal ideation
  9. Meets criteria for a DSM-V diagnosis of a moderate or severe substance use disorder in past month prior to enrollment
  10. Unstable medical condition
  11. Any medical or psychiatric condition that, in the opinion of the investigator, is severe enough to interfere with protocol adherence or ability to benefit from the intervention
  12. Any medical conditions that would preclude use of the nicotine patch (e.g., recent myocardial infarction, significant skin disorder, previous severe adverse reaction to nicotine patch, pregnant or breast feeding, assessed with our standard protocol for determining NRT eligibility)
  13. Employee or family member of the investigator or study center, or member of the same household as another research participant

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

51 participants in 2 patient groups

Experimental therapy
Experimental group
Treatment:
Behavioral: Experimental plus Nicotine Replacement Therapy
Control Therapy
Active Comparator group
Treatment:
Behavioral: Control plus Nicotine Replacement Therapy

Trial contacts and locations

4

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems